← Pulse/Companies/Compare
Scribe Therapeutics
VS
Triveni Bio

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

ST
Scribe Therapeutics

Clinical-stage biotech developing CRISPR-based gene-editing therapeutics using its proprietary CasX enzyme platform.

5 Pulse stories
TB
Triveni Bio

Triveni Bio develops genetics-informed antibody and bispecific therapeutics for immunological and inflammatory diseases.

2 Pulse stories
Total Raised
$272M
Scribe TherapeuticsTriveni Bio
Last ValuationNot disclosed
Biotech
Sector
Biotech
2018
Founded
2023
Alameda, California
HQ
Waltham, Massachusetts
Public (SCTX)
Status
Private
Scribe Therapeutics investors
No investors on record.
Triveni Bio investors
Atlas VentureCormorant Asset ManagementAscenta CapitalJanus Henderson InvestorsDeep Track CapitalOrbiMedViking Global InvestorsFidelity Management & Research

Data from Value Add Pulse coverage and company research — see the full threads for Scribe Therapeutics and Triveni Bio.